Deerfield Private Design Fund Ii, L.p. - Net Worth and Insider Trading
Deerfield Private Design Fund Ii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deerfield Private Design Fund Ii, L.p. owns 5 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , Alimera Sciences Inc (ALIM) , and Alpine Immune Sciences Inc (ALPN) among others .
Insider Ownership Summary of Deerfield Private Design Fund Ii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2018-04-30 | other: *Possible member of 10% group |
| ALIM | Alimera Sciences Inc | 2015-10-07 | 10 percent owner & other: Possible Member of 10% Group |
| ALPN | Alpine Immune Sciences Inc | 2015-06-16 | 10 percent owner & other: Possible Member of 10% Group |
 | | 2014-11-21 | 10 percent owner & other: Possible Member of 10% Group |
| | 2014-04-22 | 10 percent owner & other: Possible Members of 10% Group |
Deerfield Private Design Fund Ii, L.p. Trading Performance
Deerfield Private Design Fund Ii, L.p. Ownership Network
Deerfield Private Design Fund Ii, L.p. Owned Company Details
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Deerfield Private Design Fund Ii, L.p. is the other: *Possible member of 10% group of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Ii, L.p. made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 4,000 shares made by Thomas S Mchugh , and a net purchase of 14,000 shares made by Geoffrey Michael Glass .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 43,500 shares were bought by its insiders, resulting in a net sale of 60,475 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
Deerfield Private Design Fund Ii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Deerfield Private Design Fund Ii, L.p.. You might contact Deerfield Private Design Fund Ii, L.p. via mailing address: 780 Third Avenue, 37th Floor, New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
